How Does the Public Evaluate Vaccines for Low-Incidence, Severe-Outcome Diseases? A General-Population Choice Experiment.
F Reed JohnsonAngelyn FairchildDale WhittingtonAmit K SrivastavaJuan Marcos GonzalezLiping HuangPublished in: The patient (2022)
The results suggest that vaccines that protect against low-incidence, severe-outcome diseases, provide 'peace of mind' benefits not captured by standard health-outcome metrics. The fact that half the respondents had poorly defined vaccine preferences is a reminder of the challenges of implementing patient-centric vaccine decision making.